Biomerica Inc reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-10-15. Every row below is cited to the filing it comes from, and this page adds each new change as Biomerica Inc files it.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-15 | Reported | not named in the filing | 8-K, 2026-10-15 |
Selling to them or working with them? See who runs Biomerica Inc now and the warning signs.
Free to see. No signup.
Want the whole picture on Biomerica Inc?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Biomerica Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biomerica Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
New leaders reset buying decisions — get the Full Report on Biomerica Inc: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Biomerica Inc, with the record behind each one.
Find candidates like senior executive at Biomerica IncEvery change, in the filing's words
Reported
On October 12, 2026, David Moatazedi, a member of the Board of Directors (the "Board") of Biomerica, Inc. (the "Company"), communicated to the Board that he has determined not to stand for re-election to the Board at the Company's 2026 Annual Meeting of the Stockholders, which is set for December 11, 2026.
Tools for this story
Each opens in a new tab, filled in for Biomerica Inc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.